Glipizide
- Product NDC
- 82804-959
- 11-digit product format
- 828040959
- Labeler code
- 82804
- Product ID
- 82804-959_f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA074378
- Marketing category
- ANDA
- Marketing start
- 2025-05-01
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLIPIZIDE | 5 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | X7WDT95N5C |
| Rxcui | 310488, 310490 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ec4adfb0-aabc-95b9-ad07-5cb8f8533a09 | Product name | 2 | 20250625 |
| b1de1ca9-d9db-4f4b-2103-09e2014d30d5 | Product name | 5 | 20180912 |
| 2dee091b-3b8c-d27a-b1ba-fcb0d32e776a | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82804-959-00 | Glipizide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 82804-959-11 | Glipizide | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 82804-959-30 | Glipizide | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 82804-959-55 | Glipizide | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 82804-959-60 | Glipizide | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 82804-959-72 | Glipizide | 120 in 1 BOTTLE | TABLET | 120 | 1 | |
| 82804-959-90 | Glipizide | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 82804-959-00 | EA - Each | 82804-959 | 97d66583-f209-4989-93f9-9093f3f70994 | 1 | 2026-02-05 |
| 82804-959-11 | EA - Each | 82804-959 | 7f8ca8d3-49c6-496f-aa5c-dcab6ae1a733 | 1 | 2026-02-05 |
| 82804-959-30 | EA - Each | 82804-959 | 60272763-674d-4cba-835f-df6c73aa8bef | 1 | 2026-02-05 |
| 82804-959-55 | EA - Each | 82804-959 | 5c347754-f1bb-4af7-9c00-571d92275ba2 | 1 | 2026-02-05 |
| 82804-959-60 | EA - Each | 82804-959 | d88a0402-d587-4d22-953b-6c53271121fc | 1 | 2026-02-05 |
| 82804-959-72 | EA - Each | 82804-959 | e3e22086-be80-4ee6-b398-20f8dc45b25c | 1 | 2026-02-05 |
| 82804-959-90 | EA - Each | 82804-959 | 39e2abe6-681e-42f0-be34-8c0aa6d76cfd | 1 | 2026-02-05 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310488 | glipiZIDE 10 MG Oral Tablet | PSN | f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24 | 1 |
| 310490 | glipiZIDE 5 MG Oral Tablet | PSN | f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24 | 1 |
| 310488 | glipizide 10 MG Oral Tablet | SCD | f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24 | 1 |
| 310490 | glipizide 5 MG Oral Tablet | SCD | f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 82804-959-00 | 82804095900 | 100 TABLET in 1 BOTTLE (82804-959-00) | 100 tablet | 2026-01-12 | No | No | Current |
| 82804-959-11 | 82804095911 | 1000 TABLET in 1 BOTTLE (82804-959-11) | 1000 tablet | 2026-01-12 | No | No | Current |
| 82804-959-30 | 82804095930 | 30 TABLET in 1 BOTTLE (82804-959-30) | 30 tablet | 2026-01-12 | No | No | Current |
| 82804-959-55 | 82804095955 | 500 TABLET in 1 BOTTLE (82804-959-55) | 500 tablet | 2026-01-12 | No | No | Current |
| 82804-959-60 | 82804095960 | 60 TABLET in 1 BOTTLE (82804-959-60) | 60 tablet | 2026-01-12 | No | No | Current |
| 82804-959-72 | 82804095972 | 120 TABLET in 1 BOTTLE (82804-959-72) | 120 tablet | 2026-01-12 | No | No | Current |
| 82804-959-90 | 82804095990 | 90 TABLET in 1 BOTTLE (82804-959-90) | 90 tablet | 2026-01-12 | No | No | Current |